The endothelin-type-A receptor in dilated cardiomyopathy: another key player?

Role of RAS inhibition in the regulation of Cu/Zn-SOD in the cardiac and peripheral arterial beds in humans.

Clinical pharmacology and therapeutics·2010

Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure.

American heart journal·2003

[Medicamentous management of acute coronary syndrome without ST segment elevation].

Therapeutische Umschau. Revue therapeutique·2002

Rationale and perspective of endothelin-1 antagonism in acute heart failure.

Journal of cardiovascular pharmacology·2002

Sudden cardiac death after coronary artery bypass grafting is not predicted by signal-averaged ECG.

The Annals of thoracic surgery·2001

Tezosentan (an intravenous endothelin receptor A/B antagonist) reduces peripheral resistance and increases cardiac power therefore preventing a steep decrease in blood pressure in patients with congestive heart failure.

European journal of heart failure·2001

Immunological risk identified by single-cell multi-omics and cardiovascular outcomes.

European heart journal·2026

Gender-related risk of myocardial infarction and subclinical coronary atherosclerosis: a Danish population cohort study.

European heart journal·2026

Oral anticoagulants, cognition, and clinical outcomes in atrial fibrillation and Alzheimer's disease: a Swedish nationwide study.

European heart journal·2026

Vitronectin-driven amyloid deposition disrupts mitochondrial homeostasis via integrin-mediated pathway in a humanized mouse model of transthyretin cardiac amyloidosis.

European heart journal·2026

RUNX1-driven endothelial-to-mesenchymal transition contributes to remodelling in LMNA cardiomyopathy.

European heart journal·2026

Endometriosis and long-term risk of venous thromboembolism: a Danish nationwide study.

European heart journal·2026

Mitochondrial Omics in Macrophage Foam Cell Formation and Atherosclerosis.

Proteomics·2026

Discordance between symptomatic, echocardiographic and renal trajectories after SGLT2 inhibitor initiation in heart failure: a landmark analysis of the prospective CaRD registry.

Acta clinica Belgica·2026

Dynamic Prognostic Value of IL-6/PLT Ratio for Mortality Discrimination in Patients With Crimean-Congo Hemorrhagic Fever: Sequential ROC Analysis Throughout the Clinical Course: IL-6/PLT Ratio for Mortality Discrimination in CCHF.

Journal of medical virology·2026

Dual percutaneous management of Dunning type III iatrogenic aortic dissection during percutaneous coronary intervention: a case report.

European heart journal. Case reports·2026

Immature and mature myocardium in the pathophysiology of hypertrophic cardiomyopathy.

Journal of molecular and cellular cardiology plus·2026

Impact of calcium administration on survival and neurologic outcomes in adults with in-hospital cardiac arrest.

Resuscitation plus·2026

Related Experiment Videos

The endothelin-type-A receptor in dilated cardiomyopathy: another key player?

Related Concept Videos

Role of RAS inhibition in the regulation of Cu/Zn-SOD in the cardiac and peripheral arterial beds in humans.

Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure.

[Medicamentous management of acute coronary syndrome without ST segment elevation].

Rationale and perspective of endothelin-1 antagonism in acute heart failure.

Sudden cardiac death after coronary artery bypass grafting is not predicted by signal-averaged ECG.

Tezosentan (an intravenous endothelin receptor A/B antagonist) reduces peripheral resistance and increases cardiac power therefore preventing a steep decrease in blood pressure in patients with congestive heart failure.

Immunological risk identified by single-cell multi-omics and cardiovascular outcomes.

Gender-related risk of myocardial infarction and subclinical coronary atherosclerosis: a Danish population cohort study.

Oral anticoagulants, cognition, and clinical outcomes in atrial fibrillation and Alzheimer's disease: a Swedish nationwide study.

Vitronectin-driven amyloid deposition disrupts mitochondrial homeostasis via integrin-mediated pathway in a humanized mouse model of transthyretin cardiac amyloidosis.

RUNX1-driven endothelial-to-mesenchymal transition contributes to remodelling in LMNA cardiomyopathy.

Endometriosis and long-term risk of venous thromboembolism: a Danish nationwide study.

Mitochondrial Omics in Macrophage Foam Cell Formation and Atherosclerosis.

Discordance between symptomatic, echocardiographic and renal trajectories after SGLT2 inhibitor initiation in heart failure: a landmark analysis of the prospective CaRD registry.

Dynamic Prognostic Value of IL-6/PLT Ratio for Mortality Discrimination in Patients With Crimean-Congo Hemorrhagic Fever: Sequential ROC Analysis Throughout the Clinical Course: IL-6/PLT Ratio for Mortality Discrimination in CCHF.

Dual percutaneous management of Dunning type III iatrogenic aortic dissection during percutaneous coronary intervention: a case report.

Immature and mature myocardium in the pathophysiology of hypertrophic cardiomyopathy.

Impact of calcium administration on survival and neurologic outcomes in adults with in-hospital cardiac arrest.

Related Experiment Videos

The endothelin-type-A receptor in dilated cardiomyopathy: another key player?

Related Concept Videos

Related Articles